Zepbound

Eli Lilly’s weight-loss drug cuts diabetes risk, long-term study finds – National

by
Eli Lilly’s weight-loss drug cuts diabetes risk, long-term study finds – National

The drug tirzepatide, made popular for its treatment of Type 2 diabetes and weight loss, lowers the risk of progression to diabetes by 94 per cent among adults with prediabetes and obesity or who are overweight when taken weekly, according to a new study by the drugmaker Eli Lilly. While the study has not yet … Read more

Weight loss drug could help treat sleep apnea: Study

by
Weight loss drug could help treat sleep apnea: Study

(The Hill) — A popular weight loss drug may be able to assist in the treatment of sleep apnea, a new study found. Tirzepatide, the medicine found in the drug Zepbound and the obesity drug Mounjaro, reduced the severity of sleep apnea, a disorder that causes breathing to be interrupted, among other measures in patients … Read more